Trial intelligence / Profile preview

Autologous adipose-derived stromal vascular fraction injection in fingers of systemic sclerosis patients

KCT0003234Phase 2Recruiting

Sponsor
Seoul St. Mary's Hospital
Start
Oct 2016
Countries
1
01

Overview

Phase 2, single-arm trial of autologous adipose-derived stromal vascular fraction in systemic sclerosis (SSc), sponsored by Seoul St. Mary's Hospital. Started Oct 2016; status: recruiting.

02

Drugs

autologous adipose-derived stromal vascular fraction
03

Conditions

systemic sclerosis (SSc)

Beyond the preview

Go deeper on KCT0003234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call